U.S. Court in Connecticut Narrows Claims in Action Alleging Insurer Inflated Drug Costs
- September 04, 2020
The U.S. District Court for the District of Connecticut tossed certain claims in a putative class action alleging defendants Cigna Health and Life Insurance Company and pharmacy benefit manager (PBM) OptumRx, Inc. schemed to artificially inflate prescription drug costs in violation of health plan terms.
ARTICLE TAGS
You must be logged in to access this content.